Camurus AB
STO:CAMX

Watchlist Manager
Camurus AB Logo
Camurus AB
STO:CAMX
Watchlist
Price: 607.5 SEK -0.33% Market Closed
Market Cap: 35.7B SEK
Have any thoughts about
Camurus AB?
Write Note

Relative Value

The Relative Value of one CAMX stock under the Base Case scenario is 885.53 SEK. Compared to the current market price of 607.5 SEK, Camurus AB is Undervalued by 31%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

CAMX Relative Value
Base Case
885.53 SEK
Undervaluation 31%
Relative Value
Price
Worst Case
Base Case
Best Case

Valuation Multiples

vs History
42
vs Industry
8
Median 3Y
15.3
Median 5Y
17.4
Industry
2.6
Forward
18.4
vs History
15
vs Industry
1
Median 3Y
63.7
Median 5Y
-15.1
Industry
23
Forward
102.5
vs History
12
vs Industry
7
Median 3Y
49.3
Median 5Y
-11.6
Industry
17.8
vs History
7
vs Industry
10
Median 3Y
48
Median 5Y
-15.4
Industry
25.4
vs History
63
vs Industry
5
Median 3Y
12.2
Median 5Y
12.2
Industry
2.2
vs History
44
vs Industry
8
Median 3Y
14.5
Median 5Y
16.8
Industry
2.8
Forward
17
vs History
44
vs Industry
8
Median 3Y
16.2
Median 5Y
18.5
Industry
5.4
vs History
20
vs Industry
2
Median 3Y
52.6
Median 5Y
-10.7
Industry
13.7
Forward
77.4
vs History
15
vs Industry
2
Median 3Y
49.9
Median 5Y
-11.5
Industry
17.2
Forward
74.5
vs History
12
vs Industry
8
Median 3Y
47.4
Median 5Y
-10.8
Industry
16.5
vs History
12
vs Industry
8
Median 3Y
48.2
Median 5Y
-10.4
Industry
19.3
vs History
6
vs Industry
3
Median 3Y
20.3
Median 5Y
18.5
Industry
2

Multiples Across Competitors

CAMX Competitors Multiples
Camurus AB Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
SE
Camurus AB
STO:CAMX
35.5B SEK 21.2 134.2 113.3 119.5
JP
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
776 550.9T JPY 4 211 733 -5 347 888.9 -5 459 134.4 -5 046 864.6
US
Eli Lilly and Co
NYSE:LLY
761.8B USD 18.5 90.9 48.9 54.5
UK
Dechra Pharmaceuticals PLC
LSE:DPH
440.4B GBP 578.3 -15 783.5 3 846.3 17 702.3
DK
Novo Nordisk A/S
CSE:NOVO B
3.3T DKK 12.3 35 24.4 27.8
US
Johnson & Johnson
NYSE:JNJ
368.4B USD 4.2 25 12.1 15.8
US
Merck & Co Inc
NYSE:MRK
250.9B USD 4 20.6 10.4 12.5
CH
Roche Holding AG
SIX:ROG
208.8B CHF 3.6 18.2 10.2 12.1
CH
Novartis AG
SIX:NOVN
181.2B CHF 4.2 12.6 10 14.9
UK
AstraZeneca PLC
LSE:AZN
158.6B GBP 4.1 31.3 169.3 253.7
IE
Endo International PLC
LSE:0Y5F
155B USD 66.9 -53 248.3 622.6
P/E Multiple
Earnings Growth
SE
Camurus AB
STO:CAMX
Average P/E: 46
134.2
345%
JP
N
Nichi-Iko Pharmaceutical Co Ltd
TSE:4541
Negative Multiple: -5 347 888.9 N/A
US
Eli Lilly and Co
NYSE:LLY
90.9
451%
UK
Dechra Pharmaceuticals PLC
LSE:DPH
Negative Multiple: -15 783.5 N/A
DK
Novo Nordisk A/S
CSE:NOVO B
35
86%
US
Johnson & Johnson
NYSE:JNJ
25
-22%
US
Merck & Co Inc
NYSE:MRK
20.6
7 336%
CH
Roche Holding AG
SIX:ROG
18.2
32%
CH
Novartis AG
SIX:NOVN
12.6
21%
UK
AstraZeneca PLC
LSE:AZN
31.3
177%
IE
E
Endo International PLC
LSE:0Y5F
Negative Multiple: -53 N/A

See Also

Discover More
Back to Top